{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"rusfertide","name":"Rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":11,"objects":{"clinicaltrials-gov-nct04202965-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04202965-rusfertide:v1","objectPathId":"clinicaltrials-gov-nct04202965-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04202965-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct04202965-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#clinicaltrials-gov-nct04202965-rusfertide-v1"},"story":{"slug":"clinicaltrials-gov-nct04202965-rusfertide","version":1,"domain":"Clinical trials","dateInSource":"2025-08-20","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04202965","sourceIds":["ctg-observation-nct04202965-2025-08-20-a19784d777f9"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04202965 at 2026-11-16T01:38:51.796Z. Its registry update date was 2025-08-20, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct04202965-2025-08-20-a19784d777f9"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04202965 at 2026-11-16T01:38:51.796Z. Its registry update date was 2025-08-20, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct04202965-2025-08-20-a19784d777f9"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04202965-2025-08-20-a19784d777f9"]}],"sources":[{"id":"ctg-observation-nct04202965-2025-08-20-a19784d777f9","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04202965 · retained source version 2025-08-20:a19784d777f9f9fd9442eb137d4d318e0da9ab7310a6c27f169a2c6eafe8534c","url":"https://clinicaltrials.gov/study/NCT04202965"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f3aedaa3cba84cf5883554c4a19fd077de0e1f1e885f81b2b8d5f67ef706755b","tierARecordSha256":"7e2cdcdde574afbb5a5f30cfb77fbe57a72d1cc7320496306702c3900130254e"},"integrity":{"algorithm":"sha256","contentSha256":"9326a1a8b11ef684625520f39ba39a692a85db057fa2c6e7e2110e6b6e344c3e"}},"clinicaltrials-gov-nct04767802-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04767802-rusfertide:v1","objectPathId":"clinicaltrials-gov-nct04767802-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04767802-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct04767802-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#clinicaltrials-gov-nct04767802-rusfertide-v1"},"story":{"slug":"clinicaltrials-gov-nct04767802-rusfertide","version":1,"domain":"Clinical trials","dateInSource":"2024-03-18","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04767802","sourceIds":["ctg-observation-nct04767802-2024-03-18-fc029104809b"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04767802 at 2026-11-16T01:38:51.796Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct04767802-2024-03-18-fc029104809b"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04767802 at 2026-11-16T01:38:51.796Z. Its registry update date was 2024-03-18, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct04767802-2024-03-18-fc029104809b"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04767802-2024-03-18-fc029104809b"]}],"sources":[{"id":"ctg-observation-nct04767802-2024-03-18-fc029104809b","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04767802 · retained source version 2024-03-18:fc029104809b3957d08b3efb82597002ffd571e955134c4d5e0e878ecde98e17","url":"https://clinicaltrials.gov/study/NCT04767802"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ffcacfc382e0a1eea19ff8e90769f5b7bb43a3b256af480a7a8ff22a08210109","tierARecordSha256":"e3fd735c42d6abe09d8879ef11a9e8f173db5b05b5668809b0c4e3061697e93b"},"integrity":{"algorithm":"sha256","contentSha256":"ffa16b2a071263cf002c85c6c27c152b4b0a443c10ccd38dfb16570c129d5080"}},"clinicaltrials-gov-nct05210790-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05210790-rusfertide:v1","objectPathId":"clinicaltrials-gov-nct05210790-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05210790-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct05210790-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#clinicaltrials-gov-nct05210790-rusfertide-v1"},"story":{"slug":"clinicaltrials-gov-nct05210790-rusfertide","version":1,"domain":"Clinical trials","dateInSource":"2026-10-19","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05210790","sourceIds":["ctg-observation-nct05210790-2026-10-19-da5ff0cdcd91"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05210790 at 2026-11-16T01:38:51.796Z. Its registry update date was 2026-10-19, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct05210790-2026-10-19-da5ff0cdcd91"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05210790 at 2026-11-16T01:38:51.796Z. Its registry update date was 2026-10-19, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct05210790-2026-10-19-da5ff0cdcd91"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05210790-2026-10-19-da5ff0cdcd91"]}],"sources":[{"id":"ctg-observation-nct05210790-2026-10-19-da5ff0cdcd91","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05210790 · retained source version 2026-10-19:da5ff0cdcd91da4dc3c42873f10463ce62721a885b3a666e1fd26acd30ebdc5e","url":"https://clinicaltrials.gov/study/NCT05210790"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"af3a89b12b3dc1cc7a34049c706ef3925d3ed242da5e6ed0747e17223e9ecaee","tierARecordSha256":"b92b1a47737b382c92e42c1c0e41097c199fd404a57fa8ec330694c634cb9d7d"},"integrity":{"algorithm":"sha256","contentSha256":"93cb14f71fe1a295b3764ab93a4d6af439a2a1a62cd35cf9705dadf599296bb1"}},"clinicaltrials-gov-nct07648030-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07648030-rusfertide:v1","objectPathId":"clinicaltrials-gov-nct07648030-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07648030-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct07648030-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#clinicaltrials-gov-nct07648030-rusfertide-v1"},"story":{"slug":"clinicaltrials-gov-nct07648030-rusfertide","version":1,"domain":"Clinical trials","dateInSource":"2026-10-02","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07648030","sourceIds":["ctg-observation-nct07648030-2026-10-02-c1992cd781b4"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07648030 at 2026-11-16T01:38:51.796Z. Its registry update date was 2026-10-02, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct07648030-2026-10-02-c1992cd781b4"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07648030 at 2026-11-16T01:38:51.796Z. Its registry update date was 2026-10-02, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct07648030-2026-10-02-c1992cd781b4"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07648030-2026-10-02-c1992cd781b4"]}],"sources":[{"id":"ctg-observation-nct07648030-2026-10-02-c1992cd781b4","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07648030 · retained source version 2026-10-02:c1992cd781b489c46984212132030dc5568b1d2e29bfff119e263d9484019cf9","url":"https://clinicaltrials.gov/study/NCT07648030"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"763b6f790a53dede17095ff36d171078f7b178ad556a310c436c4b4a98353e01","tierARecordSha256":"c1250912639c81c067923e8930f8347db2c052d7204f5a594d6008d6c0500c92"},"integrity":{"algorithm":"sha256","contentSha256":"f210d4d656d24cf41182b9d597dddaef25b4152cba5198fc4d4b16bab7ce0731"}},"clinicaltrials-gov-nct07765602-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07765602-rusfertide:v1","objectPathId":"clinicaltrials-gov-nct07765602-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07765602-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#clinicaltrials-gov-nct07765602-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#clinicaltrials-gov-nct07765602-rusfertide-v1"},"story":{"slug":"clinicaltrials-gov-nct07765602-rusfertide","version":1,"domain":"Clinical trials","dateInSource":"2026-08-28","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07765602","sourceIds":["ctg-observation-nct07765602-2026-08-28-ffdf379822df"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07765602 at 2026-11-16T01:38:51.796Z. Its registry update date was 2026-08-28, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct07765602-2026-08-28-ffdf379822df"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07765602 at 2026-11-16T01:38:51.796Z. Its registry update date was 2026-08-28, and PeptideScanner's reviewed identity mapping was rusfertide.","sourceIds":["ctg-observation-nct07765602-2026-08-28-ffdf379822df"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07765602-2026-08-28-ffdf379822df"]}],"sources":[{"id":"ctg-observation-nct07765602-2026-08-28-ffdf379822df","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07765602 · retained source version 2026-08-28:ffdf379822df0a0743dc9260c7e351b9c668791c6d7d06525093a6daf58008ef","url":"https://clinicaltrials.gov/study/NCT07765602"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b2363bd0344ee0797e964d503aace95a997ca746e4d94b8f39af7a1ec0053954","tierARecordSha256":"d9948ca1e594b0c41283c94091e2b01ac408bec16084456fdb4a30b6ffa9afb7"},"integrity":{"algorithm":"sha256","contentSha256":"2bced0061d36780b539c19eb7a4a7957e4257d3c884c8ab529f2898398aee627"}},"fda-drugs-nda220605-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda220605:v1","objectPathId":"fda-drugs-nda220605-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda220605/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#fda-drugs-nda220605-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#fda-drugs-nda220605-v1"},"story":{"slug":"fda-drugs-nda220605","version":1,"domain":"Regulatory","dateInSource":"2026-08-28","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA220605","sourceIds":["fda-drugs-nda220605-2026-08-28-a7ed76fa3483"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 220605 with status AP dated 2026-08-28, and names rusfertide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda220605-2026-08-28-a7ed76fa3483"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 220605 with status AP dated 2026-08-28, and names rusfertide acetate among the application record's active ingredients.","sourceIds":["fda-drugs-nda220605-2026-08-28-a7ed76fa3483"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda220605-2026-08-28-a7ed76fa3483"]}],"sources":[{"id":"fda-drugs-nda220605-2026-08-28-a7ed76fa3483","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA220605 · original submission status AP · 2026-08-28 · dataset 2026-11-13","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA220605%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2b33d747a76e04d94ab332f99620663f7f68984f5ad3d372fad2505e1b852b83","tierARecordSha256":"a7ed76fa348381d54710f3df9120f48537736255843233f23e2657c778a43c85"},"integrity":{"algorithm":"sha256","contentSha256":"8d6f8376f68b21275cfa0ae9ce4c4a9a5c543a67bc1915e4073f83da0a13a096"}},"pubmed-pmid-37863080-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-37863080-rusfertide:v1","objectPathId":"pubmed-pmid-37863080-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-37863080-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-37863080-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#pubmed-pmid-37863080-rusfertide-v1"},"story":{"slug":"pubmed-pmid-37863080-rusfertide","version":1,"domain":"Literature metadata","dateInSource":"2025-06-05","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.","sourceIds":["pubmed-observation-pmid-37863080-2025-06-05-8b375ba88f54"]},{"id":"summary","text":"PubMed lists PMID 37863080 in The lancet. Gastroenterology & hepatology as Clinical Trial, Phase II, Multicenter Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-10-17 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-37863080-2025-06-05-8b375ba88f54"]},{"id":"paragraph-1","text":"PubMed lists PMID 37863080 in The lancet. Gastroenterology & hepatology as Clinical Trial, Phase II, Multicenter Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-10-17 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-37863080-2025-06-05-8b375ba88f54"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-37863080-2025-06-05-8b375ba88f54"]}],"sources":[{"id":"pubmed-observation-pmid-37863080-2025-06-05-8b375ba88f54","name":"PubMed","sourceClass":"A","title":"Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial. · retained source version 1:2025-06-05:current:8b375ba88f541f877d70569b68c87e9a19561a42d5828577a4a9da956b787d8c","url":"https://pubmed.ncbi.nlm.nih.gov/37863080/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"87b3c31d013d11b193cb1a3a193112894aac4038d310774ab75e6d98409aad2a","tierARecordSha256":"b435b04154e47469dfe3e29e3856b8de42dd968746820dd67310acf2d67fd6c6"},"integrity":{"algorithm":"sha256","contentSha256":"6ec18741ca091363c9106d931cb4748e89f14ee40da35e344c87e3a266926a67"}},"pubmed-pmid-38340748-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38340748-rusfertide:v1","objectPathId":"pubmed-pmid-38340748-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38340748-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-38340748-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#pubmed-pmid-38340748-rusfertide-v1"},"story":{"slug":"pubmed-pmid-38340748-rusfertide","version":1,"domain":"Literature metadata","dateInSource":"2025-06-05","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"Rusfertide for iron overload in haemochromatosis - Authors' reply.","sourceIds":["pubmed-observation-pmid-38340748-2025-06-05-64d7cba56a9d"]},{"id":"summary","text":"PubMed lists PMID 38340748 in The lancet. Gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2024-03 (month precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38340748-2025-06-05-64d7cba56a9d"]},{"id":"paragraph-1","text":"PubMed lists PMID 38340748 in The lancet. Gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2024-03 (month precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38340748-2025-06-05-64d7cba56a9d"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38340748-2025-06-05-64d7cba56a9d"]}],"sources":[{"id":"pubmed-observation-pmid-38340748-2025-06-05-64d7cba56a9d","name":"PubMed","sourceClass":"A","title":"Rusfertide for iron overload in haemochromatosis - Authors' reply. · retained source version 1:2025-06-05:current:64d7cba56a9debd9c6f9f5b6efe3dd35d35a36fb0a2b7b467fdaf227348d8cb5","url":"https://pubmed.ncbi.nlm.nih.gov/38340748/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"70743705484b569d1fd2c14346269c8e47dfeac1b0527bb4b1f8bb270b649da0","tierARecordSha256":"b62755e765b8a86a31192c7446f8727fb727fe0050fd0345e7c28f7b13f65231"},"integrity":{"algorithm":"sha256","contentSha256":"65460be8a4e7d473718761daaa9bb01d4e2141cafd7eb9f2cbdb4f6ab3c57bb9"}},"pubmed-pmid-38340749-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38340749-rusfertide:v1","objectPathId":"pubmed-pmid-38340749-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38340749-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-38340749-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#pubmed-pmid-38340749-rusfertide-v1"},"story":{"slug":"pubmed-pmid-38340749-rusfertide","version":1,"domain":"Literature metadata","dateInSource":"2025-06-05","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"Rusfertide for iron overload in haemochromatosis.","sourceIds":["pubmed-observation-pmid-38340749-2025-06-05-cc2a34cd5eb0"]},{"id":"summary","text":"PubMed lists PMID 38340749 in The lancet. Gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2024-03 (month precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38340749-2025-06-05-cc2a34cd5eb0"]},{"id":"paragraph-1","text":"PubMed lists PMID 38340749 in The lancet. Gastroenterology & hepatology as Letter, Comment, with publication-date metadata of 2024-03 (month precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38340749-2025-06-05-cc2a34cd5eb0"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38340749-2025-06-05-cc2a34cd5eb0"]}],"sources":[{"id":"pubmed-observation-pmid-38340749-2025-06-05-cc2a34cd5eb0","name":"PubMed","sourceClass":"A","title":"Rusfertide for iron overload in haemochromatosis. · retained source version 1:2025-06-05:current:cc2a34cd5eb0b7b41c31e13be45e4389350dce11af4253d615ebbf3ca151a338","url":"https://pubmed.ncbi.nlm.nih.gov/38340749/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2224e4f71b65205e1c8ff59c009274417de54b021259bc80c5ca81d0c29ecdab","tierARecordSha256":"5aea2a5e0a35235f4c96d5515bb831630ec946d2b3144a2ca8f9d96ec32068a8"},"integrity":{"algorithm":"sha256","contentSha256":"a70a0fb6b7f4cb02d2ab900e8f6aff84cb5a15af849b580220406adb1e8894d1"}},"pubmed-pmid-42868322-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42868322-rusfertide:v1","objectPathId":"pubmed-pmid-42868322-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42868322-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-42868322-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#pubmed-pmid-42868322-rusfertide-v1"},"story":{"slug":"pubmed-pmid-42868322-rusfertide","version":1,"domain":"Literature metadata","dateInSource":"2026-10-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy.","sourceIds":["pubmed-observation-pmid-42868322-2026-10-13-669295a84451"]},{"id":"summary","text":"PubMed lists PMID 42868322 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, with publication-date metadata of 2026-10-13 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42868322-2026-10-13-669295a84451"]},{"id":"paragraph-1","text":"PubMed lists PMID 42868322 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, with publication-date metadata of 2026-10-13 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42868322-2026-10-13-669295a84451"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42868322-2026-10-13-669295a84451"]}],"sources":[{"id":"pubmed-observation-pmid-42868322-2026-10-13-669295a84451","name":"PubMed","sourceClass":"A","title":"VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy. · retained source version 1:2026-10-13:current:669295a84451d46a3631e2ef9c55cecfebed46ab2dc6f1ca83a466e02fbbbba5","url":"https://pubmed.ncbi.nlm.nih.gov/42868322/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3b457d1a6b6be05d0c7ed4950ea77d52f839d1041f968e1d1f0b23c3a3e74240","tierARecordSha256":"387e2727246514fd4d05a01c8145e3429ea7c17c8bd3b1a577a49b3f49be4657"},"integrity":{"algorithm":"sha256","contentSha256":"492630d519a7bf5db63959aa96d67173036404f649ff187efc20e7add29d3ed4"}},"pubmed-pmid-42958870-rusfertide-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42958870-rusfertide:v1","objectPathId":"pubmed-pmid-42958870-rusfertide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42958870-rusfertide/","json":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.json#pubmed-pmid-42958870-rusfertide-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/rusfertide.md#pubmed-pmid-42958870-rusfertide-v1"},"story":{"slug":"pubmed-pmid-42958870-rusfertide","version":1,"domain":"Literature metadata","dateInSource":"2026-10-31","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["rusfertide"],"peptides":[{"slug":"rusfertide","url":"https://peptidescanner.com/peptides/rusfertide/"}]},"claims":[{"id":"headline","text":"Rusfertide for the treatment of polycythemia vera.","sourceIds":["pubmed-observation-pmid-42958870-2026-10-31-9cfe6fbaf2e1"]},{"id":"summary","text":"PubMed lists PMID 42958870 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2026-10-31 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42958870-2026-10-31-9cfe6fbaf2e1"]},{"id":"paragraph-1","text":"PubMed lists PMID 42958870 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2026-10-31 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42958870-2026-10-31-9cfe6fbaf2e1"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42958870-2026-10-31-9cfe6fbaf2e1"]}],"sources":[{"id":"pubmed-observation-pmid-42958870-2026-10-31-9cfe6fbaf2e1","name":"PubMed","sourceClass":"A","title":"Rusfertide for the treatment of polycythemia vera. · retained source version 1:2026-10-31:current:9cfe6fbaf2e1ddf16dce802b6db311ea7fe5404ec9b888f0ef2bedc88e3dd4c5","url":"https://pubmed.ncbi.nlm.nih.gov/42958870/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8bb7c299f12414715ce2270852e0dcd1322e97bc101413fb958d35e23c42985b","tierARecordSha256":"4531bbab1686900dd11794e0bc8c6992390c352cc49c9776dc71061124d9fa5e"},"integrity":{"algorithm":"sha256","contentSha256":"362e732d36631d8a1c9df74b4f1e56e812cf65e7d55f548ca5b7a974298f1205"}}}}
